Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical trials of new drugs for Alzheimer disease
Li-Kai Huang, Shu-Ping Chao, Chaur‐Jong Hu
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 587

Showing 1-25 of 587 citing articles:

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Zeinab Breijyeh, Rafik Karaman
Molecules (2020) Vol. 25, Iss. 24, pp. 5789-5789
Open Access | Times Cited: 1779
Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
Henrik Zetterberg, Barbara B. Bendlin
Molecular Psychiatry (2020) Vol. 26, Iss. 1, pp. 296-308
Open Access | Times Cited: 286
Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease
Amy F.T. Arnsten, Dibyadeep Datta, Kelly Del Tredici, et al.
Alzheimer s & Dementia (2020) Vol. 17, Iss. 1, pp. 115-124
Open Access | Times Cited: 267
Mechanisms of cognitive dysfunction in CKD
Davide Viggiano, Carsten A. Wagner, Gianvito Martino, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 8, pp. 452-469
Open Access | Times Cited: 256
Alzheimer’s Disease: Treatment Strategies and Their Limitations
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13954-13954
Open Access | Times Cited: 250
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Itziar de Rojas, Sonia Moreno‐Grau, Niccoló Tesi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 236
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 217
Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 195
Applications of Phyto-Nanotechnology for the Treatment of Neurodegenerative Disorders
Tanima Bhattacharya, Giselle A. Borges e Soares, Hitesh Chopra, et al.
Materials (2022) Vol. 15, Iss. 3, pp. 804-804
Open Access | Times Cited: 188
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Shofiul Azam, Md. Ezazul Haque, Rengasamy Balakrishnan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 172
Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study
Eric McDade, Jeffrey L. Cummings, Shobha Dhadda, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 168
Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial
Jin‐zhong Xiao, Noriko Katsumata, François P. Bernier, et al.
Journal of Alzheimer s Disease (2020) Vol. 77, Iss. 1, pp. 139-147
Open Access | Times Cited: 140
Gene-based therapies for neurodegenerative diseases
Jichao Sun, Subhojit Roy
Nature Neuroscience (2021) Vol. 24, Iss. 3, pp. 297-311
Open Access | Times Cited: 132
Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Tien-Wei Yu, Hsien‐Yuan Lane, Chieh‐Hsin Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8208-8208
Open Access | Times Cited: 127
Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
Li‐Kai Huang, Yi‐Chun Kuan, Ho-Wei Lin, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 125
The Potential Role of Cinnamon in Human Health
Natalia Błaszczyk, Angelina Rosiak, Joanna Kałużna‐Czaplińska
Forests (2021) Vol. 12, Iss. 5, pp. 648-648
Open Access | Times Cited: 117
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
Rola A. Bekdash
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1273-1273
Open Access | Times Cited: 113
Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
Mehdi Eshraghi, Aida Adlimoghaddam, Amir Mahmoodzadeh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3330-3330
Open Access | Times Cited: 111
Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits
Yi‐An Chen, Cheng-Hsiu Lu, Chien‐Chih Ke, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 594-594
Open Access | Times Cited: 111
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
Immacolata Vecchio, Luca Sorrentino, Anna Maria Paoletti, et al.
Journal of Central Nervous System Disease (2021) Vol. 13
Open Access | Times Cited: 110
Advanced Glycation End Products in Health and Disease
V. Prakash Reddy, Puspa Aryal, Emmanuel K. Darkwah
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1848-1848
Open Access | Times Cited: 72
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101994-101994
Closed Access | Times Cited: 66
Poor Translatability of Biomedical Research Using Animals — A Narrative Review
Lindsay J. Marshall, Jarrod Bailey, Manuela Cassotta, et al.
Alternatives to Laboratory Animals (2023) Vol. 51, Iss. 2, pp. 102-135
Open Access | Times Cited: 63
Recent advances in metal–organic frameworks for stimuli-responsive drug delivery
Fei Xing, Jiawei Xu, Yuxi Zhou, et al.
Nanoscale (2024) Vol. 16, Iss. 9, pp. 4434-4483
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top